SEC 13F Intelligence

Propel Bio Management, LLC / ABEO

Propel Bio Management, LLC’s Abeona Therapeutics Inc Position

Does Propel Bio Management, LLC own Abeona Therapeutics Inc (ABEO)? Yes — 1.33M shares worth $6M (+3.79% of its 13F portfolio) as of Q1 2026, up from 830.8K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
1.33M
% of Portfolio
+3.79%
Quarters Held
8
currently held

Position History ABEO

Reported value by quarter
Q2 ’24: $5MQ2 ’24Q3 ’24: $4MQ3 ’24Q4 ’24: $3MQ4 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $6MQ2 ’25Q3 ’25: $5MQ3 ’25Q4 ’25: $4MQ4 ’25Q1 ’26: $6MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.33M$6M+3.79%
Q4 2025830.8K$4M+3.74%
Q3 2025974.0K$5M+5.15%
Q2 2025974.0K$6M+6.71%
Q1 2025624.0K$3M+3.45%
Q4 2024624.0K$3M+3.45%
Q3 2024624.0K$4M+2.29%
Q2 20241.25M$5M+3.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of ABEO.